Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

被引：11
作者：
Accorsi, Patrizia [1 ]
Berti, Pierluigi [2 ]
de Angelis, Vincenzo [3 ]
De Silvestro, Giustina [4 ]
Mascaretti, Luca [5 ]
Ostuni, Angelo [6 ]
机构：
[1] Dept Haematol Transfus Med & Biotechnol, Osped Civile, Pescara, Italy
[2] Umberto Parini Hosp, Immunohaematol & Transfus Med, Aosta, Italy
[3] Azienda Sanit Univ Friuli Cent, Transfus Med Dept, Udine, Italy
[4] Univ Hosp Padua, Blood Transfus Serv, Padua, Italy
[5] Azienda Sanit Univ Giuliano Isontina, Transfus Med Dept, Trieste, Italy
[6] Univ Hosp Policlin, Transfus Med Unit, Bari, Italy
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2020年 / 59卷 / 04期
关键词：
COVID-19; Immune plasma; CONVALESCENT PLASMA; THERAPY;
D O I：
10.1016/j.transci.2020.102817
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
引用
收藏
页数：3
相关论文
共 19 条
[1]   Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol [J].
Arabi, Yaseen ;
Balkhy, Hanan ;
Hajeer, Ali H. ;
Bouchama, Abderrezak ;
Hayden, Frederick G. ;
Al-Omari, Awad ;
Al-Hameed, Fahad M. ;
Taha, Yusri ;
Shindo, Nahoko ;
Whitehead, John ;
Merson, Laura ;
AlJohani, Sameera ;
Al-Khairy, Khalid ;
Carson, Gail ;
Luke, Thomas C. ;
Hensley, Lisa ;
Al-Dawood, Abdulaziz ;
Al-Qahtani, Saad ;
Modjarrad, Kayvon ;
Sadat, Musharaf ;
Rohde, Gernot ;
Leport, Catherine ;
Fowler, Robert .
SPRINGERPLUS, 2015, 4 :1-8
[2]   The convalescent sera option for containing COVID-19 [J].
Casadevall, Arturo ;
Pirofski, Liise-Anne .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04) :1545-1548
[3]   Convalescent plasma as a potential therapy for COVID-19 [J].
Chen, Long ;
Xiong, Jing ;
Bao, Lei ;
Shi, Yuan .
LANCET INFECTIOUS DISEASES, 2020, 20 (04) :398-400
[4]   Use of convalescent plasma therapy in SARS patients in Hong Kong [J].
Cheng, Y ;
Wong, R ;
Soo, YOY ;
Wong, WS ;
Lee, CK ;
Ng, MHL ;
Chan, P ;
Wong, KC ;
Leung, CB ;
Cheng, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (01) :44-46
[5]  
Clinical Trials.gov, 2020, HYP PLASM CRIT PAT C
[6]   Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines [J].
Crowe, JE ;
Firestone, CY ;
Murphy, BR .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3910-3918
[7]   Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients [J].
Duan, Jun ;
Han, Xiaoli ;
Bai, Linfu ;
Zhou, Lintong ;
Huang, Shicong .
INTENSIVE CARE MEDICINE, 2017, 43 (02) :192-199
[8]  
European Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), 2017, GUIDE PREPARATION US, V19
[9]  
FDA, 2020, REC INV COVID 19 CON
[10]   The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis [J].
Mair-Jenkins, John ;
Saavedra-Campos, Maria ;
Baillie, J. Kenneth ;
Cleary, Paul ;
Khaw, Fu-Meng ;
Lim, Wei Shen ;
Makki, Sophia ;
Rooney, Kevin D. ;
Nguyen-Van-Tam, Jonathan S. ;
Beck, Charles R. .
JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (01) :80-90
12